Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Muluken Altaye Ayza, Kaleab Alemayehu Zewdie, Bekalu Amare Tesfaye, Selamawit Tesfamariam Gebrekirstos & Derbew Fikadu Berhe. (2020) Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity. Diabetes, Metabolic Syndrome and Obesity 13, pages 3627-3635.
Read now
Read now
Di Zhao, Hui Liu & Pingshuan Dong. (2019) A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension. Clinical and Experimental Hypertension 41:1, pages 75-79.
Read now
Read now
Sverre Kjeldsen, Giuseppe Mancia, Roland Schmieder, Michaela Mattheus & Thomas Unger. (2013) An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors. Expert Review of Cardiovascular Therapy 11:6, pages 673-682.
Read now
Read now
Yuji Shimizu, Fumiyasu Yamasaki, Takashi Furuno, Toru Kubo, Takayuki Sato, Yoshinori Doi & Tetsuro Sugiura. (2012) Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension. International Journal of General Medicine 5, pages 753-758.
Read now
Read now
LM Ruilope & Helmut Schumacher. (2012) Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension. Expert Opinion on Pharmacotherapy 13:16, pages 2417-2425.
Read now
Read now
Maurizio Destro, Francesca Cagnoni, Giuseppina Patrizia Dognini, Vincenzo Galimberti, Carlo Taietti, Chiara Cavalleri & Emilio Galli. (2011) Telmisartan: just an antihypertensive agent? A literature review. Expert Opinion on Pharmacotherapy 12:17, pages 2719-2735.
Read now
Read now
Articles from other publishers (20)
Caner TOPALOĞLU. (2022) Hipertansif Hastalarda Angiotensin Tip 1 Resptör Blokörleri ile Tedavi Etkisinin Egzersiz Doku Doppler Ekokardiyografik Parametrelerle DeğerlendirilmesiEvaluation of the Effect of Treatment with Angiotensin Type 1 Receptor Blockers in Hypertensive Patients by Exercise Tissue Doppler Echocardiographic Parameters. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.
Crossref
Crossref
Do-Hyung Lee, Min-Tae Kim, Hyung-Won Lee, Joo-Hui Han & Chang-Seon Myung. (2022) The combined effects of telmisartan and ramipril on hypertension and cardiovascular injury. Journal of Pharmaceutical Investigation 52:4, pages 443-451.
Crossref
Crossref
E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk & M. M. Shamuilova. (2022) Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic. Cardiovascular Therapy and Prevention 21:3, pages 3195.
Crossref
Crossref
Leidyanne Ferreira Gonçalves & Caroline Fernandes‐Santos. (2020) Telmisartan detection by UV spectrophotometry in mice drinking water. Analytical Science Advances 2:7-8, pages 408-415.
Crossref
Crossref
Chi-Hung Liu, Pi-Shan Sung, Yan-Rong Li, Wen-Kuan Huang, Tay-Wey Lee, Chin-Chang Huang, Tsong-Hai Lee, Tien-Hsing Chen & Yi-Chia Wei. (2021) Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study. PLOS Medicine 18:7, pages e1003707.
Crossref
Crossref
Jun-Hwan Jo, Do-Hyung Lee, Joo-Hui Han, Miji Lee, Keun-Woo Jang & Chang-Seon Myung. (2021) Effects of combination treatment with cilnidipine and telmisartan on hypertension, cardiovascular injury, and high blood glucose. Journal of Pharmaceutical Investigation 51:3, pages 337-346.
Crossref
Crossref
Bhupendra Raj Giri, Jaewook Kwon, Anh Q. Vo, Ajinkya M. Bhagurkar, Suresh Bandari & Dong Wuk Kim. (2021) Hot-Melt Extruded Amorphous Solid Dispersion for Solubility, Stability, and Bioavailability Enhancement of Telmisartan. Pharmaceuticals 14:1, pages 73.
Crossref
Crossref
Л.В. Распутина & Д.В. Диденко. (2021) The Effect of Combined Antihypertensive Therapy on the Morning Blood Pressure. The Results of a Single-Center Study RANOK.2.0. Кардиология в Беларуси:5, pages 700-711.
Crossref
Crossref
Junying Wang, Juan Liu, Xiangrong Song & Chunmei Fu. (2020) Simultaneous Determination of Telmisartan and Pitavastatin Calcium in Intestinal Perfusate by HPLC: Application to Intestinal Absorption Interaction Study. Pharmaceutical Nanotechnology 8:4, pages 313-322.
Crossref
Crossref
O. D. OstroumovaA. I. Kochetkov, F. T. Ageev, G. S. AnikinE. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. KhokhlovE. E. TsarevaA. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. ShikhD. A. Yakhontov. (2020) The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA. Rational Pharmacotherapy in Cardiology 16:2, pages 175-190.
Crossref
Crossref
E. V. Sayutina, L. I. Butorova, E. M. Tuaeva & M. A. Osadchuk. (2020) Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits. Cardiovascular Therapy and Prevention 19:1, pages 106-117.
Crossref
Crossref
E. V. Sayutina, L. I. Butorova, E. M. Tuaeva & M. A. Osadchuk. (2020) Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits. Cardiovascular Therapy and Prevention 19:1, pages 106-117.
Crossref
Crossref
Ah Ram Lee, Seok Young Kwon, Du Hyung Choi & Eun Seok Park. (2017) Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo®) manufactured via high shear wet granulation. International Journal of Pharmaceutics 534:1-2, pages 144-158.
Crossref
Crossref
Rainer Düsing, Patrick Brunel, InYoung Baek & Fabio Baschiera. (2013) Sustained Blood Pressure-Lowering Effect of Aliskiren Compared With Telmisartan After a Single Missed Dose. The Journal of Clinical Hypertension 15:1, pages 41-47.
Crossref
Crossref
Domenico Galzerano, Sara Di Michele, Giuseppe Paolisso, Bernardino Tuccillo, Diana Lama, Sabino Carbotta, Antonio Cittadini, Michele Adolfo Tedesco & Carlo Gaudio. (2012) A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients. Journal of the Renin-Angiotensin-Aldosterone System 13:4, pages 496-503.
Crossref
Crossref
Akihiro Noda, Hiroshi Fushiki, Yoshihiro Murakami, Hiroshi Sasaki, Sosuke Miyoshi, Hirotoshi Kakuta & Shintaro Nishimura. (2012) Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques. Nuclear Medicine and Biology 39:8, pages 1232-1235.
Crossref
Crossref
Manish Maladkar, Vijay Kumar Verma, Keshav A. Narsikar, Rajan D. Walinjkar, W. R. Patil, N. J. S. Saggu & Suresh P. Kulkarni. (2012) Triple drug combination of telmisartan, amlodipine and hydrochlorothiazide in the treatment of essential hypertension. Open Journal of Internal Medicine 02:02, pages 67-71.
Crossref
Crossref
Ji Hei ChaHye Ryon LeeKwan Chang KimMin-Sun ChoYoung Mi Hong. (2012) Changes of Gene Expressions in Spontaneously Hypertensive Rat Model After Losartan Treatment. Korean Circulation Journal 42:11, pages 761.
Crossref
Crossref
James E. Frampton. (2011) Telmisartan. Drugs 71:6, pages 651-677.
Crossref
Crossref
Jiu-Chang Zhong, Jia-ying Ye, Hai-yan Jin, Xi Yu, Hui-min Yu, Ding-liang Zhu, Ping-jin Gao, Dong-yang Huang, Manfred Shuster, Hans Loibner, Jun-min Guo, Xi-yong Yu, Bing-xiu Xiao, Zhao-hui Gong, Josef M. Penninger & Gavin Y. Oudit. (2011) Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. Regulatory Peptides 166:1-3, pages 90-97.
Crossref
Crossref